Floatz logo

Zeprumetostat

Chronic Postsurgical Pain

University Hospital, Strasbourg, FranceSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Chronic Postsurgical Pain cohort.

Asset / SponsorPhaseRating
Amitriptyline
Federico II University
Phase 4BB
Oliceridine
Tianjin Medical University General Hospital
Phase 4BB
N-Acetyl-L-Cysteine
Vanderbilt University Medical Center
Phase 4BB
Fuzuloparib
University Hospital, Strasbourg, France
Phase 3B
Ketamine Intravenous Infusion
NYU Langone Health
Phase 3B

Same molecule, other indications

Zeprumetostat is also rated in:

Obese Patients With Prostate Cancer DiseaseDormant
B
Indicative ·
60 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
B
Indicative ·
58 / 100
View asset →
Vitamin D DeficiencyDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →